A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The stromal microenvironment and particularly the macrophage component of primary tumors influence their malignant potential. However, at the metastatic site the role of these cells and their mechanism of actions for establishment and growth of metastases remain largely unknown. METHODOLOGY/PRINCIPAL FINDINGS: Using animal models of breast cancer metastasis, we show that a population of host macrophages displaying a distinct phenotype is recruited to extravasating pulmonary metastatic cells regardless of species of origin. Ablation of this macrophage population through three independent means (genetic and chemical) showed that these macrophages are required for efficient metastatic seeding and growth. Importantly, even after metastatic growth is established, ablation of this macrophage population inhibited subsequent growth. Furthermore, imaging of intact lungs revealed that macrophages are required for efficient tumor cell extravasation. CONCLUSION/SIGNIFICANCE: These data indicate a direct enhancement of metastatic growth by macrophages through their effects on tumor cell extravasation, survival and subsequent growth and identifies these cells as a new therapeutic target for treatment of metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Clinical studies and experimental animal models suggest that TAM commonly plays a pro-tumoral role in various ways [89, 96, 97].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,374
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“They probably differentiate from monocytes precursors that are restricted to blood and seed most macrophages but it cannot be ruled out that they cross-differentiate from other resident macrophages as has been described in some immune responses [61].”
BackgroundDissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911 · cited 2×
“This ability of tumor cells to establish themselves at the metastatic site is considered one of the major rate limiting steps in metastasis [1].”
BackgroundMicroenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 2×
“no direct evidence for macrophages influencing the events subsequent to homing of metastatic cells [22].”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“This metastasisassociated CD11b+macrophage population is different from the classically defined inflammatory Gr1+CCR2+CX3CR1 macrophages and Gr1-CCR2-CX3CR1 tissue macrophages [62] and is also distinct from other recently identified macrophage populations in the primary tumor microenvironment such as myeloid suppresso…”
BackgroundTumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 1×
“This distinct phenotypes give further support to the notion of the tumor microenvironment educating the recruited macrophages to give functions that are advantageous to the growing tumor cells [66].”
BackgroundSelf-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“To test the hypothesis that macrophage dependency is a general phenomena for breast cancer pulmonary metastasis, experimental metastasis assays were performed in nude mice using the metastatic variants of MDA-231 human breast cancer cell lines, 3475 and 4173 (kind gifts from Dr. Joan Massague (MSKCC, New York)”
MethodMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 3×
“In part, this tumor promotion by macrophages is due to their role in regulating angiogenesis [45] and to their ability to enhance tumor cell motility, invasion and intravasation (reviewed in [11]).”
BackgroundSelf-citationParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256 · cited 1×
“Studies in primary tumors however, have also revealed major roles for the microenvironment in modulating malignancy including significant roles for resident cells such as fibroblasts and adipocytes, as well as haematopoietic cells [8,9,10,11,12,13].”
Background
Cited by
Items 401–500 of 674
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Mojsilović, S. B., Mojsilović, S. S., Bjelica, S., & Santibanez, J. F. (2021) · Developmental Dynamics · doi:10.1002/dvdy.339 · Cited by 29
“In both melanoma and liver cancer, PMN-MDSCs increase transendothelial migration of transformed cells by integrin (MAC-1)-ICAM-1 interaction, while neutrophils and inflammatory monocytes, like cancer MDSCs, facilitate extravasation when associated with cancer cells.(112,124,125) Increasing evidence supports a correlat…”
BackgroundBarth, N. D., Mendive‐Tapia, L., Subirós‐Funosas, R., Ghashghaei, O., Lavilla, R., Maiorino, L., He, X., Dransfield, I., Egeblad, M., & Vendrell, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202113020 · Cited by 28
Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer
Minas, T. Z., Candia, J., Dorsey, T. H., Baker, F. S., Tang, W., Kiely, M. L., Smith, C. J., Zhang, A. L., Jordan, S. V., Obadi, O. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29235-2 · Cited by 29
New tricks for metastasis-associated macrophages
Qian, B., & Pollard, J. W. (2012) · Breast Cancer Research · doi:10.1186/bcr3143 · Cited by 29
“Particularly, a popula tion of metastasisassociated macrophages has been identified that promotes breast cancer metastasis [3].”
BackgroundSelf-citationImmunotherapy Targeting Tumor-Associated Macrophages
Liu, Y., & Wang, R. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.583708 · Cited by 28
“In addition, several studies show that the activation of the CCL2/CC chemokine receptor (CCR) 2 axis is very important in MAMmediated metastasis (66, 67, 69).”
BackgroundThe role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma
Xiong, K., Qi, M., Stoeger, T., Zhang, J., & Chen, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1000927 · Cited by 28
“Therefore, the number of tumor cells that occurs extravasation was significantly reduced when macrophages are depleted (89).”
BackgroundRecent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer
Kumar, A., Lunawat, A. K., Kumar, A., Sharma, T., Islam, M. M., Kahlon, M. S., Mukherjee, D., Narang, R. K., & Raikwar, S. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02765-2 · Cited by 27
“Additionally, TAMs release vascular endothelial growth factor (VEGF), leading to increased vascular permeability [51].”
Dabrosin, N., Juul, K. S., Georgsen, J. B., Andrup, S., Schmidt, H., Steiniche, T., Øllegaard, T. H., & Bønnelykke‐Behrndtz, M. L. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000515 · Cited by 28
Mohamedali, K. A., Li, Z., Starbuck, M. W., Wan, X., Yang, J., Kim, S., Zhang, W., Rosenblum, M. G., & Navone, N. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2943 · Cited by 25
Cancer and the metastatic substrate
Arvelo, F. A., Sojo, F. J., & Cotte, C. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.701 · Cited by 29
“This process promotes extravasation and the establishment and growth of tumour cells, possibly by increasing endothelial permeability [23].”
BackgroundThe Promise of Immunotherapy in the Treatment of Hepatocellular Carcinoma
El-Khoueiry, A. B. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175230 · Cited by 25
Genetic Models of Macrophage Depletion
Hua, L., Shi, J., Shultz, L. D., & Ren, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7837-3_22 · Cited by 26
Iurca, I., Tirpe, A., Zimța, A., Moldovan, C. S., Gulei, D., Slabý, O., Condorelli, G., & Berindan‐Neagoe, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00870 · Cited by 25
“The same macrophages are essentials for the metastatic seeding and growth as shown by the macrophages depletion experiments that inhibited further metastatic growth even after earlier formation of metastatic colonies (27).”
BackgroundChung, H., Gyu-mi, P., Na, Y. R., Lee, Y., Choi, H., & Seok, S. H. (2024) · Theranostics · doi:10.7150/thno.88917 · Cited by 26
“One of these bisphosphonates, clodronate exhibits antitumor properties with reduced TAMs tumor infiltration, tumor burden and metastasis in various preclinical tumor models [20, 23, 24].”
BackgroundVEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer
Lynn, K. D., Roland, C. L., & Brekken, R. A. (2010) · Cancers · doi:10.3390/cancers2020970 · Cited by 28
“Furthermore, depletion of macrophages after tumor cell seeding at the metastatic site is sufficient to significantly reduce metastatic burden in pre-clinical models of breast cancer [61].”
Ponert, J. M., Schwarz, S., Haschemi, R., Müller, J., Pötzsch, B., Bendas, G., & Schlesinger, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191303 · Cited by 26
Aldawsari, H. M., Gorain, B., Alhakamy, N. A., & Md, S. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1648478 · Cited by 23
“Non-immune mechanisms provide an important gateway for the development of tumours and their distal seeding; this includes the process of angiogenesis and metastasis [38].”
BackgroundUnderstanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
Mussa, A., Ismail, N. H., Hamid, M., Al-Hatamleh, M. A. I., Bragoli, A. J., Hajissa, K., Mokhtar, N. F., Mohamud, R., Uskoković, V., & Hassan, R. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03218-1 · Cited by 24
Immune Modulation of Metastatic Niche Formation in the Bone
Cheng, X., & Wang, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765994 · Cited by 25
“At the distant organs, metastasis-associated macrophages (MAMs), a distinct population of TAMs, were first described in mouse models of breast cancer lung metastasis (9).”
BackgroundSalmaninejad, A., Layeghi, S. M., Falakian, Z., Golestani, S., Kobravi, S., Talebi, S., & Yousefi, M. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01417-w · Cited by 25
“Of note, it has been implied that the rate of extravasation and metastasis is significantly reduced following the loss of macrophages [132].”
BackgroundMethodInfluentialMyeloid heme oxygenase‐1 promotes metastatic tumor colonization in mice
Lin, H., Chiang, M., Chang, P., & Chau, L. (2015) · Cancer Science · doi:10.1111/cas.12604 · Cited by 28
Cavassani, K. A., Meza, R. J., Habiel, D. M., Chen, J., Montes, A., Tripathi, M., Martins, G. A., Crother, T. R., You, S., Hogaboam, C. M., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1695 · Cited by 24
Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment
Batoon, L., & McCauley, L. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.763846 · Cited by 22
“While the specific mechanism underlying the macrophage contribution in CTC extravasation is not fully understood, it has been shown that direct tumor cell-macrophage interaction is required for this process (101) (Figure 1).”
BackgroundThe Role of Innate Immune Cells in Tumor Invasion and Metastasis
Huang, Y., Busuttil, R. A., & Boussioutas, A. (2021) · Cancers · doi:10.3390/cancers13235885 · Cited by 24
“Macrophage colonystimulating factor (M-CSF) is critical for the development of these macrophages [60], as well as the enhancement of macrophage-mediated extravasation of tumor cell [61].”
BackgroundMacrophages in prostate cancer: dual roles in tumor progression and immune evasion
Liu, R., Lü, J., Liu, J., Liao, Y., Guo, Y., Shi, P., Wang, Z., Wang, H., & Lai, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06519-x · Cited by 26
“Direct interactions between tumor cells and TAMs have been noted as tumor cells traverse the endothelial layer and infiltrate blood vessels [75].”
A Permanent Window for Investigating Cancer Metastasis to the Lung
Borriello, L., Traub, B. C., Coste, A., Oktay, M. H., & Entenberg, D. R. (2021) · Journal of Visualized Experiments · doi:10.3791/62761 · Cited by 21
Jing, H., Wu, X., Xiang, M., Wang, C., Novakovic, V. A., & Shi, J. (2023) · Cancers · doi:10.3390/cancers15071957 · Cited by 25
“Once recruited to the metastatic site, monocytes differentiate into metastasisassociated macrophages (MAMs) within the underlying tissue and then induce tumor cell extravasation by VEGF-mediated increase in vascular permeability [144].”
BackgroundThe Brain Pre-Metastatic Niche: Biological and Technical Advancements
Geissler, M., Jia, W., Kiraz, E. N., Kulacz, I., Liu, X., Rombach, A., Prinz, V., Jussen, D., Kokkaliaris, K. D., Medyouf, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210055 · Cited by 22
“• Direct cytokine regulation between tumor cells and astrocytes [92]; • IL-23 upregulation in metastasis-associated astrocytes [59]; • CCL2-recruited TAMs promote metastatic outgrowth and angiogenesis [93,94]; • Immune escape through T-cell suppression at the early metastatic site [28]; • Immune shielding through plat…”
BackgroundExperimental and spontaneous metastasis assays can result in divergence in clonal architecture
Serrano, A., Weber, T., Berthelet, J., El-Saafin, F., Gadipally, S., Charafe‐Jauffret, E., Ginestier, C., Mariadason, J. M., Oakes, S. R., Britt, K. L., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05167-5 · Cited by 25
“Inexperimental metastasis assays, cells are most often injected directly into the tail vein, and they are known to be trapped in lung capillaries several minutes after the injection 15 – 17 .”
BackgroundTn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease
Tumoglu, B., Keelaghan, A. P., & Avci, F. Y. (2023) · Glycobiology · doi:10.1093/glycob/cwad083 · Cited by 22
Future perspectives of prostate cancer therapy.
Gururajan, M., Posadas, E. M., & Chung, L. W. K. (2012) · PubMed Central · doi:10.3978/j.issn.2223-4683.2012.01.03 · Cited by 23
Hesketh, A. J., Maloney, C. W., Behr, C. A., Edelman, M. C., Glick, R. D., Al‐Abed, Y., Symons, M. H., Soffer, S. Z., & Steinberg, B. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145197 · Cited by 22
“Previous studies examining TAMs have largely focused on tumor cell intravasation and the role of macrophages at the primary site, and only recently has attention been turned to macrophages’ influence at metastatic foci [11, 24, 67].”
A high-fat diet aggravates osteonecrosis through a macrophage-derived IL-6 pathway
Zhou, Z., Pan, C., Wang, N., Zhou, L., Shan, H., Gao, Y., & Yu, X. (2019) · International Immunology · doi:10.1093/intimm/dxz002 · Cited by 21
Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing
Zins, K., & Abraham, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_17 · Cited by 24
A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer
Korentzelos, D. K., Clark, A. M., & Wells, A. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197304 · Cited by 21
How to target small cell lung cancer
Hamilton, G., Rath, B., & Ulsperger, E. (2015) · Oncoscience · doi:10.18632/oncoscience.212 · Cited by 23
“Metastasis is initiated by digestion of extracellular matrix with matrix metalloproteinases (MMPs) and stimulation of angiogenesis via VEGF production [52, 53].”
BackgroundGenna, A., Duran, C. L., Entenberg, D. R., Condeelis, J. S., & Cox, D. (2023) · Cancers · doi:10.3390/cancers15072092 · Cited by 22
“Macrophages play an important role in promoting metastatic seeding [18,19] and we previously detected stromal macrophages in contact with tumor cells arriving at the metastatic site [22].”
BackgroundLi, F., Gao, C., Huang, Y., Qiao, Y., Xu, H., Liu, S., & Wu, H. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.108803 · Cited by 24
“Metastasis-associated macrophages (MAMs) are one of the most abundant immune cell types in the metastatic tumor niche in mouse models of MBC [137,138].”
Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
Koliaraki, V., Henriques, A. R., Prados, A., & Kollias, G. A. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190457 · Cited by 22
Cancer: evolutionary, genetic and epigenetic aspects
Lichtenstein, A. V. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0010-6 · Cited by 21
Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer
Shen, Q., Murakami, K., Sotov, V., Butler, M. O., Ohashi, P. S., & Reedijk, M. (2024) · Science Advances · doi:10.1126/sciadv.ado8275 · Cited by 20
“Pulmonary macrophages facilitate tumor cell extravasation and the establishment of metastasis ( 62 ).”
BackgroundMetastasis-promoting functions of myeloid cells
Kusmartsev, S. A. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10278-y · Cited by 22
“Qian et al. [34] further confirmed this by inoculating breast cancer cells into the tail vein of macrophage-depleted mice using L-clodronate treat-ment.”
An emerging role for BAG3 in gynaecological malignancies
Marco, M. D., Falco, A., Iaccarino, R., Raffone, A., Mollo, A., Guida, M., Rosati, A., Chetta, M., Genovese, G., Caro, F. D., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01446-2 · Cited by 19
Lu, C., Liu, Y., Miao, L., Kong, X., Li, H., Chen, H., Zhao, X., Zhang, B., & Cui, X. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5599 · Cited by 21
“…they attempt to attach and extrude through the vessel wall with the assistance of macro‑ phages, and the extravasation rate decreases significantly after the loss of macrophages, indicating that macrophages have an important role in promoting the extravasation of circulating tumor cells (58,59).”
BackgroundTumor Associated Macrophages as Therapeutic Targets for Breast Cancer
Lao, L., Fan, S., & Song, E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_16 · Cited by 21
“that TAMs play in tumor cell extravasation [32, 178].”
Surface-Modified Macrophages Facilitate Tracking of Breast Cancer-Immune Interactions
Joshi, B. P., Hardie, J. M., Mingroni, M. A., & Farkas, M. E. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00509 · Cited by 20
Hillers‐Ziemer, L. E., Williams, A. E., Janquart, A., Grogan, C., Thompson, V., Sánchez, A., & Arendt, L. M. (2021) · Cancers · doi:10.3390/cancers13051005 · Cited by 20
Bertolini, G., Cancila, V., Milione, M., Russo, G. L., Fortunato, O., Zaffaroni, N., Tortoreto, M., Centonze, G., Chiodoni, C., Facchinetti, F., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.014 · Cited by 19
“This subset can in fact favor the extravasation of tumor cells at distant sites through the release of VEGF-A,(38) which can support their growth.(43) Notably, chemotherapy may exacerbate the tumor release of CCL2 and consequently recruitment of CCR2 IMs to both primary andmetastatic sites.”
BackgroundLee, C., Kim, S., Jeong, C., Cho, I., Jo, J., Han, I., & Bae, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042157 · Cited by 18
“A study on macrophage deficiency caused by a colony-stimulating factor-1 (Csf1) null mutation showed a dramatic decline in metastatic cell seeding in a TV model, which revealed that tumor cell seeding is strongly dependent on CSF-1 expression, which is crucial for macrophage recruitment into the secondary site [9].”
BackgroundPerivascular tumor-associated macrophages and their role in cancer progression
Bahri, M., Anstee, J. E., Opzoomer, J. W., & Arnold, J. N. (2023) · Essays in Biochemistry · doi:10.1042/ebc20220242 · Cited by 19
Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
Kitamura, T., Kato, Y., Brownlie, D., Soong, D. Y. H., Sugano, G., Kippen, N., Li, J., Doughty-Shenton, D., Carragher, N. O., & Pollard, J. W. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0234 · Cited by 18
“In mouse models of breast cancer pulmonary metastasis, a distinct population of TAMs termed metastasis-associated macrophages (MAM) promotes extravasation of circulating cancer cells, as well as subsequent survival and persistent growth at the metastatic site (6).”
BackgroundSelf-citationOf Cytometry, Stem Cells and Fountain of Youth
Gałkowski, D., Ratajczak, M. Z., Kocki, J., & Darżynkiewicz, Z. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9733-5 · Cited by 19
“lation of metastasis associated macrophages at metastatic sites promotes tumor cell extravasation, seeding and persistent growth [155].”
BackgroundMcCubbrey, A. L., Barthel, L., Mould, K. J., Mohning, M. P., Redente, E. F., & Janssen, W. J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00141.2016 · Cited by 17
“hCD68-rtTA is not exempt from nonspecific myeloid targeting, but represents improvement over LysM and c-fms (CSF1R) driven systems (1, 22, 24, 32, 41, 43), particularly the off-target activation of neutrophils (Table 2).”
BackgroundMethodMacrophages in the premetastatic and metastatic niche: key functions and therapeutic directions
Qi, Y., Sun, D., Zhai, X., Chen, F., Niu, J., & Zhu, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06556-6 · Cited by 18
Inhibition of CDC42 reduces macrophage recruitment and suppresses lung tumorigenesis in vivo
Zhang, B., Zhang, J., Xia, L., Luo, J., Zhang, L., Xu, Y., Zhu, X., & Chen, G. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1828916 · Cited by 17
“In the tumor microenvironment of metastasis, macrophages prime to the metastatic site and create a suitable environment for tumor extravasation and growth [26,27].”
BackgroundRoles for growth factors and mutations in metastatic dissemination
Nataraj, N. B., Marrocco, I., & Yarden, Y. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210048 · Cited by 17
Microenvironmental Control of the Breast Cancer Cell Cycle
Guo, X., Wu, Y., Hathaway, H. J., & Hartley, R. S. (2012) · The Anatomical Record · doi:10.1002/ar.22417 · Cited by 18
“…cells and alteration of the stromal cell population including cancer associated fibroblasts, macrophages, and other infiltrating leukocytes, as well as changes to the stromal matrix (Orimo and Weinberg, 2006; Hu and Polyak, 2008; Butcher et al., 2009; Qian et al., 2009; Lyons et al., 2011).”
BackgroundFernandez, A., Thompson, E. J., Pollard, J. W., Kitamura, T., & Vendrell, M. (2019) · Angewandte Chemie · doi:10.1002/ange.201910955 · Cited by 16
Self-citationThe portrayal of macrophages as tools and targets: A paradigm shift in cancer management
Jain, N., Srinivasarao, D. A., Famta, P., Shah, S., Vambhurkar, G. B., Shahrukh, S., Singh, S. B., & Srivastava, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121399 · Cited by 17
Feigelman, G., Simanovich, E., Brockmeyer, P., & Rahat, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11030768 · Cited by 18
“TAMs are also implicated in the seeding and growth of metastatic cells [23,24].”
BackgroundNichotherapy for stem cells: There goes the neighborhood
Lévesque, J.-P., Winkler, I. G., & Rasko, J. E. J. (2012) · BioEssays · doi:10.1002/bies.201200111 · Cited by 19
“In these mouse models of tumors, macrophages were depleted with liposomes loaded with the clodronate [77] or inactivated with function-blocking antibodies for the chemokine CCL2 or antagonists of the interaction between CSF-1 and its receptor [85, 86].”
BackgroundTonquèze, O. L., Lee, J., & Vasudevan, S. (2012) · RNA Biology · doi:10.4161/rna.20806 · Cited by 16
“Tumor associated macrophages produce cytokines and factors like TNFα that assist circulating tumor cells, promote metastasis and induce quiescence in some tumor cells, enabling their chemoresistance.(36-41) The mTOR pathway responds to nutrient and growth signals to regulate catabolic and anabolic processes, in partic…”
BackgroundMohamedali, K. A., Cao, Y. J., Cheung, L. H., Hittelman, W. N., & Rosenblum, M. G. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0165 · Cited by 16
Pontis, F., Roz, L., Fortunato, O., & Bertolini, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1116783 · Cited by 15
“Macrophages that bind to CTCs play a crucial role in tumor cell intra and extravasation steps, supporting CTC seeding and survival at distant sites (111).”
BackgroundGómez-Cambronero, J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9753-x · Cited by 15
Myeloid cells: Prime drivers of tumor progression
Toh, B., Toh, B., Abastado, J., & Abastado, J. (2012) · OncoImmunology · doi:10.4161/onci.22196 · Cited by 15
Possible Role of Arginase-1 in Concomitant Tumor Immunity
Korrer, M. J., & Routes, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091370 · Cited by 16
“Tumor associated macrophages (TAMs) are known to be protumorigenic and known to actively suppress the immune system through the production of suppressive immune mediators [20–22].”
Functional significance of macrophages in pancreatic cancer biology
Hu, H. X., Jiao, F., Han, T., & Wang, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-4127-2 · Cited by 15
Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer
Birtolo, C., Go, V. L. W., Ptasznik, A., Eibl, G., & Pandol, S. J. (2015) · Pancreas · doi:10.1097/mpa.0000000000000531 · Cited by 15
“Thus, TAMs and MDSCs can be recruited by signals from the tumor and other inflammatory cells and secrete cytokines that may promote cancer progression and metastasis.(51) Similar to Th1 and Th2 lymphocytes, macrophages can be divided into two principal subtypes: M1macrophages that produce cytokines with inhibitory fun…”
BackgroundVascular adhesion protein‐1 as indicator of breast cancer tumor aggressiveness and invasiveness
Lai, Y. C., Chang, S., Kostoro, J., Kwan, A., & Chai, C. (2018) · Apmis · doi:10.1111/apm.12885 · Cited by 15
“One study reported that macrophages directly enhanced metastatic growth through their effects on tumor cell extravasation (24).”
BackgroundTumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful
Szulc-Kiełbik, I., & Kiełbik, M. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_4 · Cited by 14
CD47-mediated immune evasion in early-stage lung cancer progression
Chuang, C., Zhen, Y., Ma, J.-Y., Lee, T.-H., Hung, H.-Y., Wu, C.-C., Wang, P., Huang, C.-T., Huang, M.-S., Hsiao, M., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150066 · Cited by 16
Rojas, A., Araya, P., Romero, J. A., Delgado‐López, F., González, I., Añazco, C. C., & Pérez-Castro, R. (2018) · Cancer Microenvironment · doi:10.1007/s12307-018-0214-4 · Cited by 14
Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 Disruption
Ding, C., Sun, X., Wu, C., Hu, X., Zhang, H., & Yan, J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801112 · Cited by 15
“These results are in agreement with previous data showing promotion of metastasis by CD11bF4/80 MAM (29, 32).”
ResultMacrophage Origin, Metabolic Reprogramming and IL-1β Signaling: Promises and Pitfalls in Lung Cancer
Guilbaud, E., Gautier, E. L., & Yvan‐Charvet, L. (2019) · Cancers · doi:10.3390/cancers11030298 · Cited by 19
“The relevance of these MAMs in helping cancer cells to leave blood vessels and promote lung adenocarcinoma metastasis in mice was previously illustrated through their recruitment to extravasating pulmonary metastatic cells regardless of species of origin [186].”
BackgroundInflammation: What role in pediatric cancer?
Morgenstern, D. A., & Anderson, J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24008 · Cited by 16
“Furthermore, it has recently been demonstrated that TAMs are instrumental in facilitating metastatic spread of breast carcinoma [28,29].”
BackgroundZhang, J., Su, Y., Wang, X., Yao, X., & Du, J. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.2001 · Cited by 17
Immune Regulation of the Metastatic Process
Pulido, Á. D. M., & Ruffell, B. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.004 · Cited by 14
“Similarly, there is a diminution in foci size when the presence or function of macrophages is interfered with (Qian et al. 2009; Qian et al. 2011; Kitamura et al. 2015b; Qian et al. 2015), indicative of an important role for macrophages in the growth phase of metastasis.”
BackgroundSalah, A., Li, Y., Wang, H., Qi, N., & Wu, Y. (2021) · DNA and Cell Biology · doi:10.1089/dna.2020.6087 · Cited by 14
“Clodronate encapsulated into liposomes (clo-drolip), which is taken up by M f s due to their phagocytic ability, was found to limit M f s’ infiltration and the metastatic growth in breast and lung cancer models (Zeisberger et al. , 2006; Hiraoka et al. , 2008; Qian et al. , 2009).”
Busà, R., Bulati, M., Badami, E., Zito, G., Maresca, D. C., Conaldi, P. G., Ercolano, G., & Ianaro, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.907572 · Cited by 16
“Similar results were obtained in TRMs-depleted transgenic mouse model (Csf1), showing that alveolar macrophages depletion did not affect the dissemination of mammary tumor cells (Qian et al., 2009).”
ResultDelprat, V., Huart, C., Féron, O., Soncin, F., & Michiels, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.961753 · Cited by 15
“Indeed, monocyte (or macrophage) infiltration into secondary tumor sites strongly increases metastatic formation, notably via increasing cancer cell extravasation and seeding into secondary tumor site (36, 40).”
BackgroundDysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein
Li, W., Zhu, H., Zhao, X., Brancho, D., Liang, Y., Zou, Y., Bennett, C. L., & Chow, C.-W. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00300-15 · Cited by 14
“mice was carried out as described previously (31).”
MethodSelf-citationA Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden
Starosolski, Z. A., Courtney, A. N., Srivastava, M., Guo, L., Stupin, I. V., Metelitsa, L. S., Annapragada, A., & Ghaghada, K. B. (2021) · Contrast Media & Molecular Imaging · doi:10.1155/2021/6641384 · Cited by 12
“Growing evidence suggests that TAMs carry out critical roles in essentially every stage of disease progression including tumor growth, angiogenesis, metastasis, and treatment resistance to conventional and emerging targeted therapies [7, 8].”
BackgroundSystemic Influences of Mammary Cancer on Monocytes in Mice
Robinson, A., Burgess, M. O., Webb, S., Louwe, P. A., Ouyang, Z., Skola, D., Han, C. Z., Batada, N. N., González‐Huici, V., Cassetta, L., et al. (2022) · Cancers · doi:10.3390/cancers14030833 · Cited by 12
Self-citationZebrafish Models of Paediatric Brain Tumours
Basheer, F., Dhar, P., & Samarasinghe, R. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179920 · Cited by 14
Li, J., Zhao, C., Wang, D., Wang, S., Dong, H., Wang, D., Yang, Y., Li, J., Cui, F., He, X., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03300-7 · Cited by 13
“They secrete various proteolytic enzymes that degrade the extracellular matrix (ECM) around tumor cells [35], regenerate the tumor vascular system by upregulating pro-angiogenic molecules [36], and promote tumor-cell extravasation [37], thereby establishing a suitable environment for tumor cell colonization at distant…”
BackgroundSelf-citationDual effect of vitamin D3 on breast cancer-associated fibroblasts
Łabędź, N., Anisiewicz, A., Stachowicz-Suhs, M., Banach, J., Kłopotowska, D., Maciejczyk, A., Gazińska, P., Piotrowska, A., Dzięgiel, P., Matkowski, R., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-11961-z · Cited by 15
“…the reduction in CCL2, MMP-2, and TNC production/activity induced by calcitriol in CAFs of almost every origin is associated with impairment of the same processes that promote metastasis, such as CCL2-driven macrophage recruitment involved in angiogenesis and intravasation of cancer cells [71, 72].”
BackgroundTumor-associated macrophages in canine visceral hemangiosarcoma
Kerboeuf, M., Haugeberg, D. A., Olsen, T., Sørling, L. K., Koppang, E. O., Moe, L., & Haaland, A. H. (2023) · Veterinary Pathology · doi:10.1177/03009858231179947 · Cited by 11
“3,19,47 They also promote tumor progression by inducing genetic instability, remodeling the extracellular matrix, promoting angiogenesis, and inhibiting the adaptive immune response.”
BackgroundModels for Monocytic Cells in the Tumor Microenvironment
Lee, S. W. L., Adriani, G., Kamm, R. D., & Gillrie, M. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35723-8_7 · Cited by 12
Willrodt, A., Beffinger, M., Vranova, M., Protsyuk, D., Schüler, K., Jadhav, M., Heikenwälder, M. F., van den Broek, M. F., Borsig, L., & Halin, C. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.008 · Cited by 11
Stock, C. M. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_68 · Cited by 12
The pro-tumorigenic responses in metastatic niches: an immunological perspective
Mirzapour, M. H., Heidari‐Foroozan, M., Razi, S., & Rezaei, N. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02950-4 · Cited by 13
The Innate Immune Microenvironment in Metastatic Breast Cancer
Tommasi, C., Pellegrino, B., Diana, A., Palafox, M., Orditura, M., Scartozzi, M., Musolino, A., & Solinas, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11205986 · Cited by 12
“Chemokin MCP-1 and CCL2 synthesis, produced by both tumor and strom l cells [33], mediates the r cruitment of C-C chemokine receptor 2 (CCR2) onocytes (receptor for CCL2) and their subsequent differentiation i to metastasis-associ ted macr pha es (MAMs) [34,35].”
BackgroundInfluentialKitamura, T., Doughty-Shenton, D., Pollard, J. W., & Carragher, N. O. (2019) · Journal of Visualized Experiments · doi:10.3791/58841 · Cited by 11
Self-citationLow infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors
Volodko, N., Gutor, T., Petronchak, O. A., Huley, R., Dúcka, M., Šmarda, J., Borsig, L., Beneš, P., & Knopfová, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-48051-1 · Cited by 12
Boussommier-Calleja, A. (2020) · Bioengineering Innovative Solutions for Cancer · doi:10.1016/b978-0-12-813886-1.00013-9 · Cited by 10
de Roquetaillade, C., Durand, M., Beaucoté, V., Guillemin, J., Chadjichristos, C. E., Roquilly, A., & Chousterman, B. G. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000712 · Cited by 11
Macrophages and tumor progression: on the way to macrophage-specific therapy
Чердынцева, Н. В., Митрофанова, И. В., Buldakov, M. A., Стахеева, М. Н., Patysheva, M. R., Zavjalova, M. V., & Kzhyshkowska, J. G. (2017) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2017-4-61-74 · Cited by 10
Globally profiling sialylation status of macrophages upon statin treatment
Wang, D., Nie, H., Ozhegov, E., Wang, L., Zhou, A., Li, Y., & Sun, X. (2015) · Glycobiology · doi:10.1093/glycob/cwv038 · Cited by 11
“Experimental studies using mouse models confirm that genetic and chemical ablation of macrophages leads to an inhibition of tumor progression and reduced rate of metastasis [8,9,10,11].”
BackgroundSalmaninejad, A., Layeghi, S. M., Falakian, Z., Foroushani, P. S., Golestani, S., Pourghazi, F., Kobravi, S., & Yousefi, M. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02055-0 · Cited by 9
“In mouse models of breast cancer lung metastasis, metastatic cell growth after tumor cell seeding required continuous macrophage recruitment [83, 86] and could be reduced by conditional macrophage suppression [86].”
Metadata
- Authors
- Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W.
- Affiliations
- Albert Einstein College of Medicine (US)
- Churchill Hospital (GB)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Pollard, Jeffrey W.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-10
- Volume
- 4
- Issue
- 8
- Pages
- e6562
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2721818
- OpenAlex
- W2117776343
- Cited by
- 664
- References
- 70
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 26 · 2023: 30 · 2022: 50 · 2021: 60 · 2020: 43 · 2019: 45 · 2018: 49 · 2017: 39 · 2016: 38 · 2015: 44 · 2014: 38 · 2013: 48 · 2012: 42
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (PO1#CA100324)
- National Cancer Institute (P01CA100324, R01CA094173, P30CA013330)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, breast cancer metastasis, tumor cell extravasation, lung metastasis, metastatic seeding, metastatic growth, macrophage depletion, tumor microenvironment, therapeutic target
- MeSH terms
- Animals, Cell Division, Disease Models, Animal, Female, Macrophages, Mammary Neoplasms, Experimental, Neoplasm Metastasis, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.